Faculty
Hematology Division
Morey A. Blinder, MD
Professor
Department of Medicine
Hematology Division
Department of Pathology & Immunology
Clinical Interests
- Disorders of iron metabolism
- Sickle cell disease
- Immune-mediated hematologic disease
- Bleeding and thromboembolic disorders
Research Interests
- Treatment of iron overload disorders and iron deficiency
- Management of sickle cell disease
- Treatment of ITP and TTP
Contact
- 314-362-8814 (office)
- 314-696-1391 (fax)
- mblinder@wustl.edu
- Hematology Division
Mail Stop 8125-0022-01
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - Suite 1101 Wohl Hospital (office)
Biosketch
| Education | |
|---|---|
| 1973-1977 | BS, University of Notre Dame, Notre Dame, IN |
| 1977-1981 | MD, St. Louis University School of Medicine, St. Louis, MO |
| Post-graduate Training | |
| 1981-1984 | Resident in Internal Medicine, Department of Medicine, University of Illinois School of Medicine, Chicago, IL |
| 1984-1986 | Fellow in Hematology, Department of Internal Medicine, University of Washington School of Medicine, Seattle, WA |
| 1986-1990 | Post-doctoral Research Fellow, Division of Hematology-Oncology, Washington University School of Medicine, St. Louis, MO |
| Academic Positions | |
| 1990-1998 | Assistant Professor, Division of Laboratory Medicine, Washington University School of Medicine, St. Louis, MO |
| 1994-present | Medical Director, Wohl Hematology Laboratory |
| 1996-present | Associate Member, Alvin J. Siteman Cancer Center |
| 1998-2013 | Associate Professor of Medicine and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO |
| 2013-present | Professor of Medicine and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO |
| 2017-present | Associate Clinical Director, Division of Hematology, Washington University School of Medicine, St. Louis, MO |
| University & Hospital Appointments & Committees | |
| 1990-present | Barnes-Jewish Hospital Medical Staff |
| 2000-present | Medical Staff Association, Barnes-Jewish Hospital |
| 2005-2007 | Vice Chair of the Executive Committee of the Faculty Council, Washington University School of Medicine |
| 2007-present | Transfusion Committee, Barnes-Jewish Hospital |
| 2010-2019 | Associate Director, Hematology-Oncology Fellowship Program |
| 2014-present | Mentors in Medicine Board of Directors, Division of Medical Education, Washington University School of Medicine |
| 2015-present | Hemostasis Subcommittee of the BJC/BJH Pharmacy and Therapeutics Committee |
| 2016-present | Courtesy Assistant Professor, Goldfarb School of Nursing at Barnes-Jewish College |
| Board Certification | |
| 1984 | Diplomate of the American Board of Internal Medicine |
| 1987 | Diplomate of the American Board in Medical Oncology |
| 1988 | Diplomate of the American Board in Hematology |
| Honors & Awards | |
| 1987-1989 | Fellow of the American Heart Association, Missouri Affiliate |
| 1995 | Outstanding Teacher for the 1994-95 Academic Year, Department of Internal Medicine, Washington University School of Medicine |
| 1999 | Dr. Neville Grant Award for Clinical Excellence |
| 2001-2020 | Listed in Best Doctors in America |
| 2001-2019 | Listed in Castle Connolly America's Top Doctors |
| 2004-present | Missouri Genetic Disease Advisory Committee, Appointed by Governor Bob Holden; Reappointed by Governor Matt Blunt 2006; Reappointed by Governor Jay Nixon 2010 |
| 2008-present | Chairman, Sickle Cell Anemia Standing Committee, State of Missouri, Department of Health and Senior Services |
| 2017 | Distinguished Faculty Teaching Award, Department of Medicine House Staff |
| 2019 | Teaching Faculty of the Year, Internal Medicine Residency, Washington University |
| Professional Societies | |
| 1992 | American Society of Hematology |
| 1993 | American College of Physicians, Member |
| 1995 | Academy of Clinical Laboratory Physicians and Scientists |
| Consulting Relationships & Board Memberships | |
| 2008-2011 | Data and Safety Monitoring Board, National Institute of Neurologic Disorders and Stroke Desferoxamine in Intracranial Hemorrhage Trial |
| 2011-present | Chairman, Safety Monitoring Committee, National Heart, Lung and Blood Institute (NHLBI), Safety to Reduce Iron Deficiency (STRIDE) Study |
| 2011-present | Panel Member, NCCN Guidelines - Cancer and Chemotherapy-Induced Anemia |
| 2020-present | Steering Committee, Agios Pharmaceuticals |
